Wu H, Wu B, Fang Z, Wu Z, Hou Y, Deng Y
Heliyon. 2024; 10(12):e32998.
PMID: 38988566
PMC: 11234027.
DOI: 10.1016/j.heliyon.2024.e32998.
Gupta A, Singh M, Singh B
Front Pharmacol. 2024; 15:1380371.
PMID: 38766631
PMC: 11100334.
DOI: 10.3389/fphar.2024.1380371.
Yang Q, Hu Y, Guo H, Xia Y, Zhang Y, Fang W
Front Pharmacol. 2021; 12:771487.
PMID: 34955843
PMC: 8696478.
DOI: 10.3389/fphar.2021.771487.
Pacheco C, Gomes de Gomes M, da Silva Neto M, Parisotto A, Dos Santos R, Maciel T
Pharmacol Rep. 2021; 74(1):135-147.
PMID: 34739705
DOI: 10.1007/s43440-021-00331-2.
Saib S, Delavenne X
Pharmaceutics. 2021; 13(10).
PMID: 34683838
PMC: 8539483.
DOI: 10.3390/pharmaceutics13101544.
Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment.
Huang P, Wang G, Su Y, Zhou Y, Huang W, Zhang R
Theranostics. 2019; 9(20):5755-5768.
PMID: 31534517
PMC: 6735370.
DOI: 10.7150/thno.36163.
A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
Naimo G, Guarnaccia M, Sprovieri T, Ungaro C, Conforti F, Ando S
Int J Mol Sci. 2019; 20(15).
PMID: 31366017
PMC: 6695675.
DOI: 10.3390/ijms20153717.
Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways.
Li S, Wang R, Wu B, Wang Y, Song F, Gu Y
Naunyn Schmiedebergs Arch Pharmacol. 2019; 392(9):1169-1180.
PMID: 31098695
DOI: 10.1007/s00210-019-01657-8.
Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.
Lindamulage I, Vu H, Karthikeyan C, Knockleby J, Lee Y, Trivedi P
Sci Rep. 2017; 7(1):10298.
PMID: 28860494
PMC: 5578999.
DOI: 10.1038/s41598-017-10972-0.
P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance.
Tuguntaev R, Chen S, Eltahan A, Mozhi A, Jin S, Zhang J
ACS Appl Mater Interfaces. 2017; 9(20):16900-16912.
PMID: 28463476
PMC: 5545886.
DOI: 10.1021/acsami.7b03877.
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Hegyi M, Arany A, Semsei A, Csordas K, Eipel O, Gezsi A
Oncotarget. 2016; 8(6):9388-9398.
PMID: 27566582
PMC: 5354739.
DOI: 10.18632/oncotarget.11543.
Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.
Xu L, Lei J, Jiang D, Zhou L, Wang S, Fan W
Cancer Biol Ther. 2015; 16(12):1794-801.
PMID: 26529585
PMC: 4847829.
DOI: 10.1080/15384047.2015.1095409.
Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes.
Ding L, Zhang B, Zhan C, Yang L, Wang Z
BMC Complement Altern Med. 2014; 14:249.
PMID: 25033983
PMC: 4223591.
DOI: 10.1186/1472-6882-14-249.
Pharmacogenomics can improve antipsychotic treatment in schizophrenia.
Xu Q, Wu X, Xiong Y, Xing Q, He L, Qin S
Front Med. 2013; 7(2):180-90.
PMID: 23606027
DOI: 10.1007/s11684-013-0249-3.
Lack of association between expression of MRP2 and early relapse of colorectal cancer in patients receiving FOLFOX-4 chemotherapy.
Mirakhorli M, Shayanfar N, Abdul Rahman S, Rosli R, Abdullah S, Khoshzaban A
Oncol Lett. 2012; 4(5):893-897.
PMID: 23162618
PMC: 3499608.
DOI: 10.3892/ol.2012.889.
Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.
Jin M, Arya P, Patel K, Singh B, Silverstein P, Bhat H
Alcohol Clin Exp Res. 2010; 35(1):132-9.
PMID: 21039635
PMC: 3058808.
DOI: 10.1111/j.1530-0277.2010.01330.x.
Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants.
Yang Y, Noh K, Han C, Kim S
Molecules. 2010; 15(9):6332-48.
PMID: 20877225
PMC: 6257698.
DOI: 10.3390/molecules15096332.
Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
Liu Z, Ma Y, He Y, Zhang P, Zhou Y, Qin H
Mol Biol Rep. 2010; 38(3):1769-75.
PMID: 20835928
DOI: 10.1007/s11033-010-0291-z.
Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.
Liu Z, He Y, Zhou Y, Zhang P, Qin H
Mol Biol Rep. 2010; 38(5):3075-82.
PMID: 20111907
DOI: 10.1007/s11033-010-9975-7.
Management of the patient with medically refractory epilepsy.
Granata T, Marchi N, Carlton E, Ghosh C, Gonzalez-Martinez J, Alexopoulos A
Expert Rev Neurother. 2009; 9(12):1791-802.
PMID: 19951138
PMC: 3761964.
DOI: 10.1586/ern.09.114.